Skip to content

Clinical trials

Completed Hepatitis B trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Status: Completed Country / region: United States Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20021
20034
20049
200510
20066
20072
20086
20095
201010
20114
20129
20136
20148
20154
20174
20186
20196
20209
20217
20223
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences16
National Institute of Allergy and Infectious Diseases (NIAID)11
GlaxoSmithKline10
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)9
Dynavax Technologies Corporation8
Bristol-Myers Squibb5
University of North Carolina, Chapel Hill5
Assembly Biosciences4
National Institutes of Health Clinical Center (CC)3
University of California, Davis3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B136
Hepatitis B, Chronic27
HIV Infections20
Hepatitis C20
Hepatitis19
Acquired Immunodeficiency Syndrome7
Fibrosis7
Carcinoma, Hepatocellular6
Liver Diseases6
Kidney Failure, Chronic5

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.